Fundraising FoxSafar Partners — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
GelMEDIX is a Cambridge-based biotech developing injectable hydrogel-based cell and gene therapies for vision-restoring retinal treatment.
BiotechCambridge, US
Max Cotler(Executive Officer)inNasim Annabi(Director)Reza Dana(Director)Arthur Driscoll(Executive Officer, Director)
BoardMichael Cima(Director)Parinaz Motamedy(Director)in
Co-investorsBeacon AngelsBoston Harbor Angels
Gradiant designs and builds water and wastewater treatment plants using its proprietary technology stack, helping industrial customers reduce freshwater withdrawal, reuse wastewater, and return clean water to the environment.
Advanced ManufacturingCircular EconomyCleantechClimate TechDeep TechWoburn, US
Anurag Bajpayee(Co-Founder & Executive Chairman)inPrakash Govindan(Co-Founder & CEO)inMark Danchak(Director)Jeff Luse(Director)Keith Wilson(Director)Ashok Belani(Director)
Co-investorsCapTableClearvision VenturesCloudStone CapitalGRC SinogreenWarburg PincusWAVE Equity Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.